Brief: Hofseth Biocare Q1 Revenue at NOK 44 Million
12/05/2023 06:57
May 12 (Reuters) - Hofseth Biocare Q1 adjusted free cash flow NOK 100 thousand. * Q1 revenue NOK 44 million * Q1 adjusted EBITDA NOK -19.8 million
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering